OPM announces a 6 million euros bank financing

Oncodesign Precision Medicine announces a 6 million euros bank financing from Caisse d’Épargne Bourgogne Franche Comté, Crédit Agricole de Champagne Bourgogne and Société Générale

Dijon (France), October 5 2023 , at 6:00pm CEST Oncodesign Precision Medicine (OPM) (ISIN :FR001400CM63 ; Mn emonic : ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancer announces the successful signing of a financing agreement of 6 M granted by three regional banks: Caisse d’Épargne Bourgogne Franche Comté, Crédit Agricole Champagne Bourgogne and Société Générale.
This financing is guaranteed by BPI France and PCG.